PYY and NPY: Control of gastric motility via action on Y1 and Y2 receptors in the DVC

Neurogastroenterology and Motility

Volumn 9, Issue 2, 1997, Pages 109-116

  Chen, C H ^a   Stephens Jr , R L ^a   Rogers, R C ^a,b  

^a 302 Hamilton Hall ^*  (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Dorsal vagal complex; Motility; NPY; PYY; Stomach

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; HORMONE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROTRANSMITTER; PANCREAS POLYPEPTIDE; PEPTIDE YY; PROTIRELIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; FEEDING; HORMONE RELEASE; ILEUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; STOMACH FUNCTION; STOMACH MOTILITY; VAGUS REFLEX;

EID: 0030913172     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2982.1997.d01-26.x     Document Type: Article

References (58)

1. Tatemoto K, Mutt V. Isolation of two novel candidate hormones using a chemical method for finding naturally occuring polypeptides. Nature 1980; 285: 417-18.
2. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 1982; 79: 2514-18.
3. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide Y Yand pancreatic polypeptide. Nature 1982; 296: 659-60.
4. Bottcher G, Alumets J, Hakanson R, Sundler F. Co-existence of glicetin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study. Regul Pept 1986; 13: 283-91.
5. Lundberg J M, Tatemoto K, Terenius L P M, Mutt V, Hokfelt T, Hamberger B. Localization of peptide Y Y (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 1982; 79: 4471-5.
6. Broome M, Hokfelt T, Terenius L. Peptide Y Y (P Y Y) - immunoreactive neurons in the lower brain stem and spinal cord of rat. Acta Physiol Scand 1985; 125: 349-52.
7. Ekman R, Wahlestedt C, Bottcher G, Sundler F, Hakanson R, Panula P. Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Peptides 1986; 16: 157-68.
8. Happola O, Wahlestedt C, Ekman R, Soinila S, Panula P, Hakanson R. Peptide YY-like immunoreactivity in sympathetic neurons of the rat. Neuroscience 1990; 39: 225-30.
9. McDonald T J, Wang Y F, Mao Y K, Broad R M, Cook M A, Daniel E E. P Y Y: a neuropeptide in the canine enteric nervous system. Regul Pept 1993; 44: 33-48.
10. O'Donohue T L, Chronwall B M, Pruss R M, et al. Neuropeptide Y and peptide Y Y neuronal and endocrine systems. Peptides 1985; 6: 755-68.
11. Taylor I L. Distribution and release of peptide Y Y in dog measured by specific radioimmunoassay. Gastroenterology 1985; 88: 731-7.
12. Taylor I L. Pancreatic polypeptide family: pancreatic polypeptide, neuropeptide Y and peptide Y Y. In: The Gastrointestinal system II, Handbook of Physiology. Oxford: Oxford University Press, 1989, pp. 475-543.
13. Pappas T N, Chang A M, Debas H T, Taylor I L. Peptide Y Y release by fatty acids is sufficient to inhibit gastric empting in dog. Gastroenterology 1986; 91: 1386-9.
14. Read N W, MacFarlane A, Kingsman R I, et al. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1983; 86: 274-80.
15. Sheikh S P, Holst J J, Orskov C, Ekman R, Schwartz T W. Release of P Y Y from pig intestinal mucosa; luminal and neural regulation. Regul Pept 1989; 26: 253-66.
16. Greeley G H., Jeng Y J, Gomez G, et al. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 1989; 124: 1438-43.
17. Lluis F, Gomez G, Fujimura M, Greeley G H, Thompson J C. Peptide Y Y inhibits pancreatic secretion by inhibiting cholecystokinin release in the dog. Gastroenterology 1988; 94: 137-42.
18. Hernandez E J, Whitcomb D J, Vigna S R, Taylor I L. Saturable binding of circulating peptide Y Y in the dorsal vagal complex of rats. Am J Physiol 1994; 266 (29): G511-16.
19. Al-Saffar A, Hellstrom P M, Nylander G. Correlation between peptide YY-induced myoelectric activity and transit of small-intestinal contents in rats. Scand J Gastroenterol 1985; 20: 577-82.
20. Bilchik A J, Hines O J, Adrian T E, et al. Peptide Y Y is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo. Gastroenterology 1993; 105: 1441-8.
21. Buell M G, Harding R K. Effects of peptide Y Y on intestinal blood flow distribution and motility in the dog. Regul Pept 1989; 24: 195-208.
22. Wager-Page S A, Ghazali B, Anderson W, Veale W L, Davison J S. Neuropeptide Y, peptide Y Y, and pancreatic polypeptide modulate duodenal and colonic motility at a thoracic spinal site in rats. Peptides 1992; 13: 807-13.
23. Chen C H, Rogers R C. Central inhibitory action of peptide YY on gastric motility in rats. Am J Physiol 1995; 269 (38): R787-92.
24. Yang H, Tache Y. Peptide YY in the dorsal vagal complex stimulates gastric secretion through vagal pathways in rats. Am J Physiol 1996; 268: G943-8.
25. Geoghegan JG, Lawson DC, Cheng CA, Opara E, Taylor IL, Pappas TN. Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog. Gastroenterology 1993; 105 (4): 1069-77.
26. Lee MC, Lawson DC, Pappas TN. Neuropeptide Y functions as a physiologic regulator of cephalic phase acid secretion. Regul Pept 1994; 52 (3): 227-34.
27. Matsuda M, Aono M, Moriga M, Okuma M. Effects of centrally administered NPY on stress induced gastric ulcers in the rat. Jap J Gastroenterol 1995; 92 (5): 855-61.
28. Wager-Page SA, Raizada E, Veale WL, Davison JS. Spinal modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: involvement of the cholinergic nervous system. Can J Physiol Pharmacol 1993; 71 (2): 112-9.
29. Lundberg JM, Hemsem A, Rudehill A, et al. Neuropeptide Y- and alpha-adrenergic receptors in pig spleen: localization, binding characteristics, cyclic AMP effects and functional responses in control and denervated animals. Neuroscience 1988; 24: 659-72.
30. Sheikh SP, O'Hare MMT, Tortora O, Schwartz TW. Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines. J Biol Chem 1989; 264: 6648-54.
31. Sheikh SP, Roach E, Fuhlendorff J, Williams JA. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas. Am J Physiol 1991; 260 (23): G250-7.
32. Sheikh SP, Sheikh MI, Schwartz TW. Y2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am J Physiol 1989; 257 (26): F978-84.
33. Leslie RA, McDonald TJ, Robertson HA. Autoradiographic localization of peptide YY and neuropeptide Y binding sites in the medulla oblongata. Peptides 1988; 9: 1071-6.
34. Bard JA, Walker MW, Branchek TA, Weinshank RL. A human receptor for pancreatic polypeptide, neuropeptide Y and peptide YY of the Y4 subtype: cloning and pharmacological characterization. Physiologist 1995; 38: A-242.
35. Michel MC, Schlicker E, Fink K. Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro. Am J Physiol 1990; 259 (22): E131-9.
36. Wahlestedt C, Yanaihara N, Hakanson R. Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides. Regul Pept 1986; 13: 307-18.
37. Dumont Y, Fournier A, St-Pierre S, Schwartz TW, Quirion R. Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain. Eur J Pharmacol 1990; 191: 501-3.
38. Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 1992; 38: 125-67.
39. Colmers WF, Wahlestedt C. The biology of neuropeptide Y and related peptides. In: Characterization of Receptor Types for Neuropeptide Y and Related Peptides. Totowa Humana Press Inc., 1993, Chapter 5.
40. McTigue DM, Edwards NK, Rogers RC. Pancreatic polypeptide in dorsal vagal complex stimulates gastric acid secretion and motility in rats. Am J Physiol 1993; 265 (28): G1169-76.
41. Hermann GE, Rogers RC. Tumor necrosis factor-alpha in the dorsal vagal complex suppresses gastric motility. Neuroimmunomodulation 1995; 2: 74-81.
42. Raggenbass M, Vozzi C, Tribollet E, Dubois-Dauphin M, Dreifuss JJ. Thyrotropin-releasing hormone causes direct excitation of dorsal vagal and solitary tract neurons in rat brainstem slices. Brain Res. 1990; 530: 87-90.
43. Ormsbee HS, Bass P. Gastroduodenal motor gradients in the dog after pyloroplasty. Am J Physiol 1976; 230: 389-97.
44. Kosaka T, Lim RSK. Demonstration of the humoral agent in fat inhibition of gastric secretion. Proc Soc Exp Bio Med 1930; 27: 890-91.
45. Kosaka T, Lim RSK. On the mechanism of the inhibition of gastric motility by fat. An inhibitory agent from the intestinal mucosa. Chin J Physiol 1933; 7: 5-12.
46. Broadwell RD, Sofroniew MV. Serum proteins bypass the blood-brain-barriers for extracellular entry into the central nervous system. Exp Neurol 1993; 120: 245-63.
47. Chen CH, Stephens RL, Rogers RC. Reciprocal control of gastric motility by Y1 and Y2 receptors in the dorsal vagal complex. Soc Neurosci Abst 1996; 26: 159.6.
48. Baskin DG, Breininger J, Jonak Z, Schwartz MW. Fasting increases the number of arcuate nucleus neurons that express neuropeptide Y mRNA as detected by non-isotopic in situ hybridization with digoxigenin. Physiologist 1995, 38: A-250.
49. Hanson ES, Dallman MF. Adrenalectomy equally attenuates both ad lib and NPY-induced food consumption. Abstract for 'New discovery of the pancreatic polypeptide family'. 1995; A-250.
50. Kalra SP., Neuropeptide Y. A pleiotropic neuroendocrine signal: new molecular and anatomical considerations. Abstract for 'New discovery of the pancreatic polypeptide family'. 1995; A-251.
51. Leibowitz SF. Role of neuropeptide Y in the control of energy balance. Abstract for 'New discovery of the pancreatic polypeptide family'. 1995; A-252.
52. Aguirre JA, Covenas R, Dawid-Milner MS, Alonso JR, Garcia-Herdugo G, Gonzalez-Baron S. Neuropeptide Y-like immunoreactivity in the brain stem respiratory nuclei of the cat. Brain Res Bull 1989; 23: 201-7.
53. Jimenez M, Bueno L. Inhibitory effects of neuropeptide Y (NPY) on CRF and stress-induced cecal motor response in rats. Life Sci 1990; 47 (3): 205-11.
54. Penner SB, Smyth DD, Glavin GB. Effects of neuropeptide Y and (Leu31, Pro34) neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat. J Pharmacol Exp Therapeu 1993; 266: 339-43.
55. Grandt D, Dahms P, Schimiczek M, Eysselein VE, Reeve JR, Mentlein R. Proteolytic processing by dipeptidyl aminopeptidase IV generates receptor selectivity for peptide YY (PYY). Medizinische Klinik 1993; 88 (3): 143-5.
56. Ahmad S, Wang L, Ward PE. Dipeptidyl (amino) peptidase IV and aminopeptidase M metabolize circulating substance P in vivo. J Pharmacol Exp Therapeu 1992; 260 (3): 1257-61.
57. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem 1989; 264 (28): 16518-23.
58. Gross PM, Wall KM, Pang JJ, Shaver SW, Wainman DS. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am J Physiol 1990; 259 (28): R1131-8.